Examedi, Chilean healthtech, revolutionizes health with AI and expands its services

In recent years, Chilean healthtech Examedi has emerged as a critical player in the health sector, especially during the pandemic. Initially, Examedi focused on offering at-home PCR tests, an innovation directly dependent on the COVID-19 context. Despite challenges, Examedi secured a significant USD$17 million in its Series A funding, allowing it to diversify and expand its health services. The company, founded by Chileans, has evolved to integrate various new services. These include telemedicine, kinesiology, therapeutic massages, nutrition, and mental health.

More News

Next Article

China’s Meituan explores deal for Delivery Hero’s Southeast Asia arm Foodpanda

November 23, 2023

China-based food delivery giant Meituan is said to be exploring a potential acquisition of Delivery Hero SE’s business in Southeast Asia as the company looks to diversify beyond its domestic market, Bloomberg reported on Friday, quoting people familiar with the matter. Meituan has held talks with Delivery Hero about buying Southeast Asian operations that run under the Foodpanda brand, the people said, according to the report.

CDPI Emerging Markets
Previous Article

RapiCredit raised US$7M in debt investment

November 23, 2023

The Colombian online loan company RapiCredit, specializing in providing microloans to individuals without access to banking services, has secured a US$7 million debt investment from the U.S. fund Almavest. Originating from Medellín, RapiCredit has provided credit opportunities to more than 550,000 unbanked Colombians, with 36% of them becoming eligible to enter the traditional financial system after obtaining a loan from the company.

CDPI Emerging Markets
Featured Article

Ad Fontes Media Partners with The Trade Desk to Support Brand Safe Advertising

February 23, 2024

Ad Fontes Media, a company that rates news sites for reliability and bias, has announced the integration of its rating data with The Trade Desk’s programmatic advertising platform. This will allow the screening out of highly partisan, AI-generated and clickbait sites, preferentially serving ads to sites containing quality journalism. Directing ad spend to low quality sites not only wastes dollars and threatens brand safety but de-monetizes quality news operations.

CDPI Newsletter